NYSE:EWMedical Equipment
How JP Morgan’s Upgrade and 2026 Conference Spotlight Will Impact Edwards Lifesciences (EW) Investors
Earlier this month, Edwards Lifesciences announced it will participate in the 44th Annual J.P. Morgan Healthcare Conference on January 12, 2026, featuring a presentation by CEO Bernard Zovighian and CFO Scott Ullem via a live webcast on its investor relations site.
This high-profile conference appearance, combined with a recent JP Morgan analyst upgrade, highlights how closely the company’s cardiovascular innovation roadmap is being followed by the market.
Building on JP Morgan’s upgraded...